Viewing Study NCT04379635


Ignite Creation Date: 2025-12-24 @ 10:32 PM
Ignite Modification Date: 2026-02-23 @ 1:10 PM
Study NCT ID: NCT04379635
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-21
First Post: 2020-05-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparing the Efficacy and Safety of a New Additional Treatment With Tislelizumab in Non-Small Cell Lung Cancer (NSCLC)
Sponsor: BeiGene
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module